Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00764920 · ClinicalTrials.gov registry record
Skin Imaging With Technologies in Development
A clinical trial of Pigmented Skin Lesion of Uncertain Nature, sponsored by University of California, Irvine.
- Active
- Registry status
- 750
- Enrollment target
- 1
- Study location
NCT00764920 is a study of Pigmented Skin Lesion of Uncertain Nature that is active but no longer recruiting, run by University of California, Irvine. The registered enrollment target is 750 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00764920, a study of Pigmented Skin Lesion of Uncertain Nature, is active but no longer recruiting, sponsored by University of California, Irvine.
- ACTIVE NOT RECRUITING
- Registry status
- 750 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to develop non-invasive imaging modalities for assessment of skin. This is a pilot study which will use multiple imaging modalities to collect information on normal and lesional skin. The researchers understand that the purpose of this study is not to evaluate any particular treatment and an investigation of a new therapeutic intervention would require an additional protocol. Skin conditions to be studied include vascular lesions, pigmentary disorders, inflammatory conditions and neoplasms.
Conditions Studied
Interventions
- DEVICE non-invasive imaging modalities for assessment of skin
Study Locations (1)
California
- Beckman Laser Institute Medical Clinic - Irvine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2008-10 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00764920
The ClinicalTrials.gov registry entry for NCT00764920 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 750 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pigmented Skin Lesion of Uncertain Nature appearing as the primary indexed condition, and to 1 intervention - of which non-invasive imaging modalities for assessment of skin is the first listed.
NCT00764920 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00764920 about?
NCT00764920 is a clinical study titled "Skin Imaging With Technologies in Development". The purpose of this research is to develop non-invasive imaging modalities for assessment of skin. This is a pilot study which will use multiple imaging modalities to collect information on normal and lesional skin. The researchers understand that the purpose of this study is not to evaluate any par...
What is the current status of trial NCT00764920?
This trial is currently active not recruiting. The enrollment target is 750 participants. The study started on 2008-10. Estimated completion is 2026-12.
What conditions does trial NCT00764920 study?
This clinical trial studies the following conditions: Pigmented Skin Lesion of Uncertain Nature.
What interventions are being tested in trial NCT00764920?
The interventions under investigation include: non-invasive imaging modalities for assessment of skin (DEVICE).
Who is sponsoring clinical trial NCT00764920?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00764920 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.